Profile of past and current clinical trials involving endothelin receptor antagonists: the novel “-sentan” class of drug.

Bruno Battistini, Nathalie Berthiaume, Nicholas F Kelland, David J Webb, Donald E Kohan

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)653-695
JournalExperimental Biology and Medicine
Issue number6
Publication statusPublished - 1 Jun 2006

Cite this